Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleFirst Med vs Vitalex Health

TeleFirst Med
Graded #399

Lower grade

vs+2.3000000000000043
Vitalex Health
Graded #337

Higher grade

The verdict

Vitalex Health takes it — 59.7/100 to 57.4/100.

Vitalex Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vitalex Health is an Atlanta-based telehealth practice offering compounded semaglutide, tirzepatide, and a lower-dose GLP-1 microdose program through partner U.S.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitalex Health +9
45
54
Dose & formulationVitalex Health +11
53
64
Clinical oversightTeleFirst Med +18
82
64
Labs & monitoringEven
52
52
FulfillmentVitalex Health +12
58
70
Contract termsEven
55
55
TeleFirst Med · left barVitalex Health · right bar

The numbers

MetricTeleFirst MedVitalex Health
WeighScore57.4/10059.7/100
GradeCC
Scorecard rank#399#337
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$199/mo (starting dose, compounded)
Coverage2 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
TeleFirst Med

Graded #399 · C

Strengths

  • Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
  • Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
  • You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
  • Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care

Where it loses points

  • Only Texas and North Carolina are confirmed — not available nationwide
  • The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
  • Small practice (about 500 patients) with limited public detail on its clinicians and program
  • No compounded or lower-cost medication option, and no medication pricing is published
Vitalex Health

Graded #337 · C

Strengths

  • Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
  • Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
  • Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
  • Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
  • Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links

Where it loses points

  • Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
  • No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
  • Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
  • Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
  • Domain was registered in April 2026 — a brand-new practice with no independent reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard